Found 21 resultsAuthor Title Type [ Year]
Filters: Author is Matthews, Abigail G [Clear All Filters]
Comparison of six statistics of genetic association regarding their ability to discriminate between causal variants and genetically linked markers. Hum Hered, 72(2), 142-52. presented at the 2011. doi:10.1159/000332006. (2011).
ABO-blood groups and risk of abdominal aortic aneurysm and peripheral obstructive artery disease: two sides of the same coin. Thromb Res, 129(1), 89-90. presented at the 2012 Jan. doi:10.1016/j.thromres.2011.09.028. (2012).
Dentin caries activity in early occlusal lesions selected to receive operative treatment: findings from the Practitioners Engaged in Applied Research and Learning (PEARL) Network. J Am Dent Assoc, 143(4), 377-85. presented at the 2012 Apr. doi:10.14219/jada.archive.2012.0180. (2012).
Level of oral health impacts among patients participating in PEARL: a dental practice-based research network. Community Dent Oral Epidemiol, 40(4), 332-42. presented at the 2012 Aug. doi:10.1111/j.1600-0528.2012.00676.x. (2012).
Outcomes of endodontic therapy in general practice: a study by the Practitioners Engaged in Applied Research and Learning Network. J Am Dent Assoc, 143(5), 478-87. presented at the 2012 May. doi:10.14219/jada.archive.2012.0208. (2012).
Effectiveness of a resin-modified glass ionomer liner in reducing hypersensitivity in posterior restorations: a study from the practitioners engaged in applied research and learning network. J Am Dent Assoc, 144(8), 886-97. presented at the 2013 Aug. doi:10.14219/jada.archive.2013.0206. (2013).
Periodontal diagnosis affected by variation in terminology. J Periodontol, 84(5), 606-13. presented at the 2013 May. doi:10.1902/jop.2012.110743. (2013).
Restoration variables and postoperative hypersensitivity in Class I restorations: PEARL Network findings. Part 2. Compend Contin Educ Dent, 34(4), e62-8. presented at the 2013 Apr.. (2013).
Substance-use screening and interventions in dental practices: survey of practice-based research network dentists regarding current practices, policies and barriers. J Am Dent Assoc, 144(6), 627-38. presented at the 2013 Jun. doi:10.14219/jada.archive.2013.0174. (2013).
Treatments for hypersensitive noncarious cervical lesions: a Practitioners Engaged in Applied Research and Learning (PEARL) Network randomized clinical effectiveness study. J Am Dent Assoc, 144(5), 495-506. presented at the 2013 May. doi:10.14219/jada.archive.2013.0152. (2013).
Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials, 39(2), 211-23. presented at the 2014 Nov. doi:10.1016/j.cct.2014.08.011. (2014).
Internet-delivered treatment for substance abuse: a multisite randomized controlled trial. Am J Psychiatry, 171(6), 683-90. presented at the 2014 Jun. doi:10.1176/appi.ajp.2014.13081055. (2014).
Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.. Addiction, 111(8), 1416-27. presented at the 2016 08. doi:10.1111/add.13375. (2016).
Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial. Addiction, 111(4), 695-705. presented at the 2016 Apr. doi:10.1111/add.13238. (2016).
Opioid, NSAID, and OTC Analgesic Medications for Dental Procedures: PEARL Network Findings. Compend Contin Educ Dent, 37(10), 710-718. presented at the 2016 Nov/Dec.. (2016).
Causes of death and expected years of life lost among treated opioid-dependent individuals in the United States and Taiwan. Int J Drug Policy, 43, 1-6. presented at the 2017 05. doi:10.1016/j.drugpo.2016.12.003. (2017).
Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States. Drug Alcohol Depend, 176, 14-20. presented at the 2017 07 01. doi:10.1016/j.drugalcdep.2017.02.024. (2017).
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend, 177, 249-257. presented at the 2017 08 01. doi:10.1016/j.drugalcdep.2017.04.020. (2017).
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. Lancet, 391(10118), 309-318. presented at the 2018 01 27. doi:10.1016/S0140-6736(17)32812-X. (2018).
Addressing identification bias in the design and analysis of cluster-randomized pragmatic trials: a case study. Trials, 21(1), 289. presented at the 2020 Mar 23. doi:10.1186/s13063-020-4148-z. (2020).
Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations. Contemp Clin Trials, 93, 106014. presented at the 2020 Jun. doi:10.1016/j.cct.2020.106014. (2020).